Abstract:Ubiquitination is a prevalent post-translational modification that controls a multitude of important biological processes. Due to the low abundance of ubiquitinated proteins, highly efficient separation and enrichment approaches are required for ubiquitinome analysis. In this work, we disclose the region-specific interactions between the hydrophobic patch of ubiquitin and polydopamine. Taking advantage of this inherent binding property, we have constructed surface-imprinted magnetic nanoparticles (NPs) for ubiquitin by sequential dopamine polymerization and surface PEGylation. The obtained molecularly imprinted polymer (MIP) NPs showed a binding constant of 2.6 × 106 L mol-1 for the template ubiquitin. The bound ubiquitin could be quantitatively released by heating to 70 °C at pH 2.0 or 90 °C at neutral (pH 7.0) conditions. The MIP NPs exhibited nano receptor-like property which not only effectively blocked the formation of branched ubiquitin chains but also selectively separated ubiquitin from the bacterial cell lysates. By incubating the MIP NPs with the lysates of 293T cells, totally 529 ubiquitinated proteins were captured, among which 287 proteins were not identified by the anti-ubiquitin monoclonal antibodies (mAbs). With the distinct merits of low cost and high stability, the as-prepared MIP NPs may be utilized either separately or as an important complement to the mAbs for the purification and enrichment of ubiquitin and ubiquitinated proteins from complex biological samples. Furthermore, due to the flexibility in modification of the binding sites during or after the imprinting reactions, the results of this work also paved the way for generation of artificial receptors for branched ubiquitin chains and polyubiquitinated proteins with higher avidity and specificity.

Next-generation sequencing of a combinatorial peptide phage library screened against ubiquitin identifies peptide aptamers that can inhibit the in vitro ubiquitin transfer cascade

Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2

Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site

In-solution enrichment identifies peptide inhibitors of protein–protein interactions

A method to identify small molecule/protein pairs susceptible to protein ubiquitination

Structural and biophysical characterisation of ubiquitin variants that specifically inhibit the ubiquitin conjugating enzyme Ube2d2

Phage Display of Two Distinct Warheads to Inhibit Challenging Proteins.

Chemoselective placement of unsaturated phosphorus electrophiles into ubiquitin for proximity-induced protein targeting

Identification of highly selective covalent inhibitors by phage display

High‐Throughput Discovery of Substrate Peptide Sequences for E3 Ubiquitin Ligases Using a cDNA Display Method

Computationally Designed Peptide Inhibitors Of The Ubiquitin E3 Ligase Scffbx4

Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes

A Potent and Selective Inhibitor for the UBLCP1 Proteasome Phosphatase.

Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1

Identification of small‐molecule binding sites of a ubiquitin‐conjugating enzyme‐UBE2T through fragment‐based screening

Construction of Nano Receptors for Ubiquitin and Ubiquitinated Proteins Based on the Region-Specific Interactions Between Ubiquitin and Polydopamine

Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide library

Targeting UBE2C for Degradation by Bioprotacs Based on Bacterial E3 Ligase

E2 Enzyme Inhibition by Stabilization of a Low-Affinity Interface with Ubiquitin.

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform

Directed Evolution Using Stabilized Bacterial Peptide Display